(Q37803363)

23 August 2017

title

Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients (English)

1 reference

systemic lupus erythematosus

23 August 2017

0 references

0 references

0 references

1 reference

1 reference

1

Michelle Petri

1 reference

23 August 2017

publication date

1 February 2011

1 reference

Current Rheumatology Reports

23 August 2017

published in

1 reference

23 August 2017

volume

13

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

77-80

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-010-0141-y

23 August 2017

exact match

0 references

cites work

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11926-010-0141-Y

Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-010-0141-Y

Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-010-0141-Y

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-010-0141-Y

Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.

21 January 2018

1 reference

12 December 2020

Hydroxychloroquine in prophylaxis of pulmonary embolism following hip arthroplasty

1 reference

12 December 2020

Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report

1 reference

12 December 2020

Hydroxychloroquine and postoperative thromboembolism after total hip replacement

1 reference

12 December 2020

Antimalarial agents: closing the gate on Toll-like receptors?

1 reference

12 December 2020

Anti–β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts

1 reference

12 December 2020

Use of antimalarial drugs as "desludging" agents in vascular disease processes

1 reference

12 December 2020

Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin

1 reference

12 December 2020

Failure of orally administered hydroxychloroquine sulphate to prevent venous thromboembolism following elective hip operations

1 reference

12 December 2020

Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy

1 reference

12 December 2020

Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8.

1 reference

12 December 2020

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

1 reference

12 December 2020

Effect of antimalarial treatment on circulating immune complexes in rheumatoid arthritis

1 reference

12 December 2020

Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug's antithrombotic effect

1 reference

12 December 2020

Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies.

1 reference

12 December 2020

Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties.

1 reference

12 December 2020

Mechanism of action of antimalarial drugs: inhibition of antigen processing and presentation

1 reference

12 December 2020

Effect of antimalarial drugs on stimulation and interleukin 2 production of human lymphocytes

1 reference

12 December 2020

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

1 reference

12 December 2020

Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling

1 reference

12 December 2020

Prevention of Postoperative Deep Venous Thrombosis in Legs by Orally administered Hydroxychloroquine Sulphate

1 reference

12 December 2020

Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?

1 reference

12 December 2020

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.

1 reference

12 December 2020

Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement

1 reference

12 December 2020

Hydroxychloroquine sulphate in prevention of deep venous thrombosis following fracture of the hip, pelvis, or thoracolumbar spine

1 reference

12 December 2020

The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface

1 reference

12 December 2020

Some rheological properties of blood during anti-rheumatoid therapy

1 reference

12 December 2020

The effect of hydroxychloroquine therapy on serum levels of immunoregulatory molecules in patients with systemic lupus erythematosus

1 reference

12 December 2020

Prevention of Postoperative Deep Venous Thrombosis and Pulmonary Embolism

1 reference

12 December 2020

TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss

1 reference

12 December 2020

Immunosuppressive potential of antimalarials

1 reference

12 December 2020

Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells

1 reference

12 December 2020

Effects of some antimalarial drugs on rat inflammatory polymorphonuclear leukocyte function

1 reference

12 December 2020

Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers

1 reference

12 December 2020

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

1 reference

12 December 2020

10.1007/S11926-010-0141-Y

Identifiers

DOI

1 reference

23 August 2017

1 reference